The current shortage of iodinated contrast in the United States due to the COVID-19 related production shutdown in China is causing severe disruptions in patient care. A new Harvey L. Neiman Health Policy Institute study outlines the most frequently used computed tomography (CT) services performed on Medicare beneficiaries as focus areas for mitigation strategies for the greatest overall impact.

The computed tomography angiography (CTA) consists of injecting contrast into the venous circulation of the patient, followed by a series of x-ray images (lower two images). The radiologist then reconstructs three dimensionally the main arteries of the brain using the computer with special software. This is a computer generated image, it is not as sharp as a regular photograph, but it is the sharpest image that can be delivered to date. In this case this CTA shows an anterior communicating artery aneurysm. Getty Images


June 1, 2022 — The current shortage of iodinated contrast in the United States due to the COVID-19 related production shutdown in China is causing severe disruptions in patient care. A new Harvey L. Neiman Health Policy Institute study outlines the most frequently used computed tomography (CT) services performed on Medicare beneficiaries as focus areas for mitigation strategies for the greatest overall impact.

The Journal of American College of Radiology (JACR) study looked at 9.6 million CTs involving iodinated contrast in the Medicare Physician/Supplier Procedure Summary file which represents 100% of Medicare Part B claims in 2019 – the latest pre-pandemic year of data available. The study found that utilization of contrast enhanced CT was highest in the outpatient hospital and emergency department settings. By body region, utilization was highest for the abdomen/pelvis, particularly in outpatient hospitals and emergency departments, followed next by chest CT. For CT angiography, the highest relative utilization relative to standard CT was of the brain followed by head/neck, and in the emergency department and hospital inpatient settings.

According to lead author, Richard Duszak, Jr., MD, Professor and Vice Chair for Health Policy and Practice in the Department of Radiology and Imaging Sciences at Emory University School of Medicine and Neiman HPI Affiliate Senior Research Fellow, “the highlighted site of service and body region differences may help guide the creation of the most impactful teams via multi-disciplinary collaboration to balance mitigation with clinical service needs.”

Computed tomography (CT) with contrast is increasingly relied upon for the diagnosis and follow up of a variety of conditions. “The results of this study can help guide current intense efforts nationally and institutionally to identify strategies to minimize or avoid iodinated contrast use by using alternative imaging modalities, contrast agents, or protocols that reduce or minimize waste resulting from individual doses,” says Dr. Duszak. “Such strategies will be most efficient and impactful when focused on the most frequently used services.”

For more information: https://www.neimanhpi.org/

Related Content of MRI Gadolinium Concerns

New Report Provides Strategies for Managing Contrast Shortage

AJR Publishes Best Practices for Iodinated Contrast Media Shortage

Voluntary Dismissal of Chuck Norris Gadolinium Case Involving Bracco

VIDEO: How Serious is MRI Gadolinium Retention in the Brain and Body? An interview with Max Wintermark, M.D.

VIDEO “Big Concerns Remain for MRI Gadolinium Contrast Safety at RSNA 2017,” An interview with Emanuel Kanal, M.D.

Radiology Has Failed to Properly Assess or Track MRI Gadolinium Contrast Safety

Recent Developments in Contrast Media

FDA Committee Votes to Expand Warning Labels on Gadolinium-Based Contrast Agents

European Medicines Agency Issues Update on Gadolinium Contrast Agents


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | Radiology Business

July 19, 2024 — GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s ...

Time July 19, 2024
arrow
News | Radiology Education

July 19, 2024 — Core tactics to address the current medical imaging and radiation therapy workforce shortage and build ...

Time July 19, 2024
arrow
News | Computed Tomography (CT)

July 18, 2024 — NeuroLogica Corp, a subsidiary of Samsung Electronics Co. Ltd., announced its latest configuration of ...

Time July 18, 2024
arrow
News | Digital Radiography (DR)

July 18, 2024 — At the Annual Meeting of AHRA (the Association for Medical Imaging Management), Agfa Radiology Solutions ...

Time July 18, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
Subscribe Now